Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation

October 2019

Zelnorm (tegaserod) will be back on your pharmacy shelves to treat irritable bowel syndrome with constipation (IBS-C) in women.

It was first approved in 2002...then taken off the market in 2007 due to reports of heart attack, stroke, and unstable angina.

Since then, it's been available on a case-by-case basis from various manufacturers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Influenza Share the Latest Advice About 2019-2020 Influenza Immunizations
E-Cigarettes Emphasize Risks of Vaping and Help Kids and Teens Stop
Medicare Be Familiar With Changes Coming to Medicare Part D in 2020
Anticoagulants Help Manage Direct Oral Anticoagulants Around Surgery
Pediatrics Weigh Options for Managing Type 2 Diabetes in Kids
Contraceptives Don't Jump to the New Progestin-Only Oral Contraceptive, Slynd (Drospirenone)
Pharmacy Practice Demystify the Ins and Outs of Compression Stockings
Vaccines Know When to Discuss HPV Vaccination With Adults Over Age 26
Antibiotics Save the Antibiotic Xenleta as a Last Resort
Immunosuppressives Stay Alert for Safety Issues With Janus Kinase Inhibitors (Xeljanz, etc)
IBS Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation